¼ÛÀ±¼·			 ¸íÀÇ

Æí¾ÈÇÑ ¹Ì¼Ò·Î ȯÀÚ¿Í ¼ÒÅëÇÏ´Â Àü¸³¼±¾Ï Àü¹®°¡

¼ÛÀ±¼· ¸íÀÇ

  • ¼Ò ¼Ó
    ¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø ºñ´¢±â°ú
  • Àü¹®ºÐ¾ß
    Àü¸³¼±Áúȯ, Á¾¾ç, ¹è´¢Àå¾Ö

¼ÛÀ±¼· ±³¼ö´Â ÃÖ±Ù 3³â°£ Àü¸³¼±¾ÏÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ ¿È, ¾Ï ´ë»ç, ¼¼Æ÷ ±â¹Ý À¯ÀüÀÚ Ä¡·á µî°ú °ü·ÃÇÑ 24ÆíÀÇ SCI ³í¹®À» ÁÖÀúÀÚ·Î ÃâÆÇÇß´Ù.
ÀÌµé ºÐ¾ß¸¦ Á¢¸ñÇÑ ³­Ä¡¼º Àü¸³¼±¾Ï ¸é¿ª °ü¹® ¾ïÁ¦ ¾à¹° Ä¡·á¿¡ ´ëÇÑ ¿¬±¸¿¡ ¸ÅÁøÇϰí ÀÖ´Ù. 2024³â ´ëÇÑ ¹è´¢Àå¾Ö ¿ä½Ç±Ý ÇÐȸ Á¦29Â÷ Çмú´ëȸ ¹× Á¦18Â÷ ½Ç¹« ¿öÅ©¼ó¿¡¼­ ¿ì¼ö³í¹®»óÀ» ¼ö»óÇϱ⵵ Çß´Ù. ºñ´¢ ÀÇÇаú ºÐ¾ß¿¡¼­ Ȱ¹ßÇÑ ¿¬±¸ Ȱµ¿À» Çϸç ȯÀÚµéÀ» Ä¡·áÇϰí ÀÖÀ¸¸ç Çа迡¼­µµ ÀÎÁ¤¹Þ°í ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¿¬¼¼´ë ÀÇ´ë Çлç
  • ¿¬¼¼´ë ÀÇ´ë ¼®»ç
  • ¿¬¼¼´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¼øÃµÇâ´ë ¼­¿ïº´¿ø ºñ´¢ÀÇÇаú ±³¼ö
  • 2013³â ¼øÃµÇâ´ëÇб³ CEO°Ç°­°úÇдëÇпø, CEOÁÖÄ¡ÀÇ
  • 2008³â ¼øÃµÇâÀÇ´ë ±³¼ö
  • 2004³â ¼øÃµÇâ´ëÇб³º´¿ø °úÀå

¼ö»ó³»¿ª

Awards List
  • Marquis Who¡®s Who in the world (2015)
  • ºñ´¢±â°úÇÐȸ ÃÖ°í³í¹®»ó - ±è¼¼Ã¶Çмú»ó (2013)
  • À¯·´ºñ´¢±â°úÇÐȸ ÃÖ¿ì¼öÃÊ·Ï»ó (2013)
  • IBC 21¼¼±â 2000¸í Áö½ÄÀÎ - 2000 outstanding intellectuals of 21st century (2010)
  • IBC 2010³â 100¸í °Ç°­ Àü¹®°¡ - Top 100 health professionals (2010)
  • Who¡®s who in medicine and health care International Biographical Centre 100´ë ÀÇÇÐÀÚ
  • 100´ë±³À°ÀÚ 2000 outstanding intellectuals of 21th century
  • Àθí»çÀüµîÀç (2009)
  • ´ëÇѳ²¼º°úÇÐȸ ÇØ¿ÜÇмú»ó (2008)
  • ´ëÇѳ²¼º°úÇÐȸ ÇØ¿ÜÇмú»ó (2007)
  • ´ëÇѺñ´¢±â°úÇÐȸ Çмú»ó (2007)
  • ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ ¿¬±¸°úÁ¦ °ø¸ð»ó (2007)
  • ¾Æ½Ã¾ÆÅÂÆò¾ç¼ºÀÇÇÐȸ ÃÖ¿ì¼ö±¸¿¬»ó (2007)
  • ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ ÇØ¿ÜÇмú»ó (2007)
  • ´ëÇѹ财Àå¾Ö ¹× ¿ä½Ç±ÝÇÐȸ ¿ì¼ö³í¹®»ó (2006)
  • ´ëÇѺñ´¢±â°úÇÐȸ Çмú»ó (2005)
  • ¼øÃµÇâ´ëÇб³¼öÇùÀÇȸ ¿ì¼ö³í¹®»ó (2002)
  • ´ëÇѳ²¼º°úÇÐȸ ¿ì¼ö³í¹®»ó (2002)
  • ³«ÃµÀÇÇлó ¼ö»ó (2002)
  • ´ëÇѳ²¼º°úÇÐȸ ¿ì¼ö³í¹®»ó (2000)

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѺñ´¢±â°úÇÐȸ ÆíÁýÀ§¿ø
  • ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ ¿¬±¸ÀÌ»ç
  • ´ëÇѳ²¼º°úÇÐȸ ÀÌ»ç
  • ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ÀÌ»ç
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö
Á¦ ¸ñ Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö
Á¦ ¸ñ Cytosine Deaminase-Overexpressing hTERT-Immortalized HumanAdiposeStemCells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö
Á¦ ¸ñ Different Prostatic Tissue Microbiomes between High- and Low-Grade Prostate Cancer Pathogenesis
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö
Á¦ ¸ñ The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement
¹ßÇ¥³âµµ 2021 ¹ßÇ¥Áö
Á¦ ¸ñ Malignant Prostate Tissue Is Associated with Different Microbiome Gene Functions
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö
Á¦ ¸ñ Biochemical Recurrence in Prostate Cancer Is Associated with the Composition of Lactobacillus: Microbiome Analysis of Prostatic Tissue
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

³­Ä¡¼º Àü¸³¼±¾ÏÀÇ Ä¡·á¸¦ À§ÇÏ¿© ¸é¿ª°ü¹®¾ïÁ¦¾à¹°, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È, ¼¼Æ÷±â¹Ý À¯ÀüÀÚ Ä¡·á ¿¬±¸ ºÐ¾ßÀ̸ç,
ÀÓ»ó ÇöÀå¿¡¼­ ÇØ°áµÇÁö ¸øÇß´ø ¹®Á¦¸¦ ÇØ°áÇϰí ÀÖÀ½.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

ȯÀÚ¿¡°Ô Æí¾ÈÇÏ°í µµ¿òÀ̵Ǵ ÀÇ»çÀÌ°í ½Í´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

ÃֽаúÇÐÀÇ ¹ßÀüÀ¸·Î Àü¿¡ ÇØ°áÇÏÁö ¸øÇß´ø ÁúȯÀ» »õ·Î¿î Ä¡·á¹ýÀÇ µîÀåÀ¸·Î ÇØ°áÇØ°¡°í ÀÖÀ¸´Ï ³¡±îÁö Èñ¹æÀ» ÀÒÁö¸»¶ó°í ¸»ÇÏ°í ½Í´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø

Á¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-709-9114

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¼øÃµÇâ´ëÇб³¼­¿ïº´¿øÀº 1974³â ÇÏ´ÃÀÇ ¶æÀ» ¹Þµé¾î ÀμúÀ» ÆîÃİ¡´Â °íÇ⸶À»À» ¸¸µé¾î °¡°Ú´Ù´Â Àΰ£»ç¶û, »ý¸íÁ¸ÁßÀÇ ¼øÃµÇâ(â÷ô¸úÁ) Á¤½ÅÀ¸·Î °³¿øÇß´Ù. 32°³ Áø·á°ú¿Í 700 º´»óÀ» ¿î¿µÇϸç 220¿©¸íÀÇ ±³¼ö¿Í 2õ¿©¸íÀÇ ±³Á÷¿øÀÌ Áø·á¿Í ¿¬±¸, ±³À°¿¡ ÃÖ¼±À» ´ÙÇϰí ÀÖ´Ù. Áö¿ª½É³úÇ÷°ü¼¾ÅÍ ÁöÁ¤, ÁßȯÀÚ½Ç È®Àå, ¾Ï½Å¼ÓÁö¿ø¼¾ÅÍ, CAR-TÄ¡·á µîÀ¸·Î ÁßÁõ Áø·á¸¦ °­È­Çϰí, ÀÇ·áÁúÆò°¡ 1µî±Þ, ÀÀ±ÞÀÇ·á±â°ü Æò°¡ Aµî±Þ, ȯÀÚ°æÇèÆò°¡ Àü±¹13À§¸¦ ºñ·ÔÇØ °¢Á¾ ÀûÁ¤¼ºÆò°¡ 1µî±ÞÀ» À¯ÁöÇÏ¸ç ¾ÈÀüÇÑ Áø·á·Î »çȸÀû Ã¥ÀÓ°ú °¡Ä¡¸¦ ±¸ÇöÇϰí ÀÖ´Ù.

¼øÃµÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¿ë»ê±¸ ´ë»ç°ü·Î 59

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä